Vice President, Investor Relations & Corporate Communications
- Employer
- IDEAYA Biosciences
- Location
- South San Francisco, CA
- Posted date
- Sep 28, 2026
View more categories
- Discipline
- Marketing, Marketing/Corporate Communications
- Required Education
- Bachelors Degree
- Position Type
- Full time
- Hotbed
- Biotech Bay
By clicking apply, your email address will be shared with the employer.
Job Details
Non-Solicitation Policy and Notice to Agencies and Recruiters:
IDEAYA's Non-Solicitation Policy strictly prohibits agencies and recruiters from any contact and communication with IDEAYA employees, managers, and leaders to submit unsolicited candidate resumes and/or to solicit business partnerships. Submission of unsolicited candidate resumes by agencies or recruiters with or without a contract in place with IDEAYA Biosciences Inc. will not create any implied obligation. Failure to comply with this policy will result in disqualification from current and future business opportunities with IDEAYA Biosciences. All recruiting and talent agency decisions are strictly managed by the internal IDEAYA Human Resources function. All communication by external agencies and recruiters must be directed to humanresources@ideayabio.com. We ask that you only email your interest once.
Job Summary
Job Description
What you’ll do:
Investor Relations
Develop and execute a comprehensive investor relations strategy aligned with IDEAYA's corporate objectives and long-term value creation strategy.
Serve as a key point of contact for institutional investors, sell-side analysts, prospective shareholders, and the investment community.
Partner closely with the CEO and CFO to prepare for quarterly earnings, investor conferences, non-deal roadshows, and individual investor meetings.
Lead the development of earnings materials, press releases, investor presentations, executive talking points, Q&A documents, and messaging surrounding corporate earnings, clinical data presentations, regulatory milestones, strategic partnerships, financing activities, and other material corporate events.
Monitor shareholder composition, analyst models, peer performance, and investor sentiment, providing strategic insights to executive leadership and the Board of Directors.
Ensure compliance with SEC disclosure requirements, Regulation FD, and public company governance standards.
Corporate Communications
Develop and execute a comprehensive corporate communications and reputation strategy that strengthens IDEAYA's reputation, credibility, and visibility across key internal and external stakeholders.
Develop and steward IDEAYA's enterprise narrative, aligning the Company's scientific innovation, clinical progress, business strategy, and commercial evolution into a compelling corporate story.
Anticipate and lead integrated communications strategies around major corporate milestones and strategic events that shape IDEAYA's reputation and long-term growth.
Oversee the development of press releases, executive communications, website content, annual reports, ESG messaging, digital communications, and other external communications materials.
Develop executive thought leadership opportunities and prepare senior leadership for media, investor, and public engagements.
Identify and proactively plan for emerging reputational opportunities and risks; drive crisis communications planning and advise executive leadership on actions that strengthen trust and protect IDEAYA's reputation.
Partner with the Human Resources, and functional leaders to develop an enterprise internal communications strategy that strengthens employee understanding of corporate strategy, major milestones, organizational priorities, culture, and the Company’s evolution.
Build and Scale the Function
Build IDEAYA's Investor Relations and Corporate Communications function from the ground up, including organizational design, operating processes, governance, systems, and communications infrastructure.
Develop a multi-year strategy to scale the function in support of the Company's continued growth and commercialization objectives.
Recruit, develop, mentor, and lead a high-performing Investor Relations and Corporate Communications team as organizational needs evolve.
Evaluate and manage external agencies, investor targeting firms, communications consultants, and other strategic partners while thoughtfully transitioning appropriate capabilities in-house over time.
Partner closely with Commercial, Clinical Development, Medical Affairs, Regulatory Affairs, Business Development, Legal, Finance, and Human Resources to ensure coordinated, consistent, and impactful communications across the organization.
Executive Leadership
Serve as a trusted strategic advisor to the CEO, CFO, Executive Leadership Team, and Board of Directors on communications strategy, investor engagement, reputation management, and external stakeholder communications.
Establish and lead enterprise communications governance to ensure consistent messaging, clear accountability, and effective cross-functional coordination.
Foster a culture of transparency, collaboration, and excellence in all external communications.
Requirements:
Bachelor's degree in Finance, Business, Communications, Life Sciences, or a related field; MBA or advanced scientific degree preferred.
15+ years of progressive leadership experience in investor relations, corporate communications, equity research, media or related roles within the biotechnology or pharmaceutical industry.
Significant experience supporting publicly traded biotechnology companies.
Strong understanding of biotechnology drug development, clinical development, regulatory pathways, and capital markets.
Demonstrated success building trusted relationships with institutional investors, research analysts, media outlets, patient advocacy groups, executive leadership teams, and Boards of Directors.
Exceptional written, verbal, and presentation skills with the ability to communicate complex scientific and financial information clearly and effectively.
Experience leading communications around clinical, regulatory, financing, and strategic corporate milestones.
Proven ability to operate effectively in a fast-paced, high-growth environment.
Experience building or significantly expanding an Investor Relations and/or Corporate Communications organization.
Experience supporting a company's evolution from clinical-stage to commercial-stage operations.
Oncology or precision medicine experience.
Experience supporting capital markets transactions.
Established relationships within the biotechnology investment community and industry media.
Experience supporting one or more commercial product launches.
Leadership Competencies
Strategic thinker with exceptional business judgment and financial acumen.
Entrepreneurial builder who enjoys creating organizations, developing talent, and establishing scalable processes.
Collaborative leader who builds strong partnerships across scientific, clinical, financial, operational, and commercial functions.
Outstanding organizational and project management skills with exceptional attention to detail.
High integrity, sound judgment, and commitment to confidentiality.
Calm and effective under pressure, particularly during periods of heightened market activity and significant corporate events.
Ability to balance strategic leadership with hands-on execution in a dynamic, growth-oriented environment.
All employees are expected to act with integrity and in full compliance with applicable laws, regulations, and IDEAYA policies, including IDEAYA’s Code of Conduct.
Employees must demonstrate good judgement and ethical behavior in all business activities, maintain patient and product safety as a top priority, and report any suspected violations of law or Company policy through appropriate channels
Total Rewards
Along with our inspiring mission, and highly collaborative and inclusive environment, IDEAYA offers a competitive total rewards package that reflects our pay-for-performance philosophy where employees are eligible to be considered for merit-based salary increases, company discretionary short-term incentive plan participation, and company discretionary stock option awards (based on board approval). Our comprehensive benefits package includes, but is not limited to, medical/dental/vision coverage (100% company paid for employees and 90% company paid for dependents), 401k, ESPP, and wellness programs.
The expected salary range for the roleof Vice President, Investor Relations & Corporate Communications is $309,000 - $381,000. The final salary offered to a successful candidate will depend on several factors that may include but are not limited to the office location where this open position is located, the final candidates’ experience within their profession, experience in the disease areas we are striving to make an impact in as a company, length of time within the industry, educational background, and performance during the interview process.
The Company complies with all laws respecting equal employment opportunities and does not discriminate against applicants with regard to any protected characteristic as defined by federal, state, and local law.
IDEAYA is an equal opportunity employer. In accordance with applicable law, IDEAYA does not discriminate in hiring or otherwise in employment based on race, color, religion, sex, national origin, age, marital or veteran status, disability, sexual orientation, or any other legally protected status. EOE/AA/Vets.
We are committed to providing reasonable accommodations to qualified individuals with disabilities. If you need assistance or an accommodation due to a disability, please get in touch with us at hr@ideayabio.com.
Company
Founded in 2015, IDEAYA Biosciences is a public, clinical-stage synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics for patient populations selected using DNA sequencing and other molecular diagnostics. Our approach integrates extensive capabilities in identifying and validating translational biomarkers with small molecule drug discovery to select patient populations most likely to benefit from the therapies we are developing. We are applying these capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality – which represents an emerging class of precision medicine targets. We believe this diversified approach will enable us to deliver the right medicine to the right patient to drive a more robust clinical response.
Stock Symbol: IDYA
- Phone
- 650-443-6209
- Location
- 5000 Shoreline Court, Ste. 300
South San Francisco
California
94080